The Evolution of Liver Cancer Market in 2024 (APAC)
Speakers
Max Nisen
Analyst
Bloomberg Intelligence
Max Nisen is a senior associate equity research analyst specializing in the pharmaceutical and biotechnology sector. Prior to joining Bloomberg Intelligence, Max was the founding health care columnist for Bloomberg Gadfly and later Bloomberg Opinion, where he wrote about the pharmaceutical industry, managed care, policy and public health. Before that, he covered business and financial news at Quartz and Business Insider. Max earned a bachelor’s degree in economics from Pomona College.
Dr. Leslie Oleksowicz
Professor of Medial Oncology
Saint Louis University Cancer Center
Leslie Oleksowicz is Professor of Medicine at Saint Louis University Cancer Center (08/2012-present). Additionally, she has a voluntary faculty appointment as Director of Medical Genitourinary Oncology, Melanoma/Sarcoma Oncology and Immuno-Oncology at The Barrett Cancer Center of University Hospital, University of Cincinnati (09/2003-present). She specializes in the treatment of genitourinary cancer including prostate, bladder, urothelial, testicular and renal cell tumors, as well as melanoma, and sarcoma. She is a pioneer in the use of dose-intensive high dose Interleukin-2 for metastatic renal cell carcinoma and melanoma. She is currently involved in clinical trials for Stage IV breast cancer, melanoma, carcinoma, myeloma, and osteonecrosis. She is the Director of the Hematology/Oncology Clinical Trial Program and oversees a robust and comprehensive selection of clinical trials in the benign and malignant hematologic disorder space. She has served as an investigator in early clinical trials evaluating Ruxolitinib, Fedratinib Pacritnib and non-JAK inhibitors. She also has knowledge and can discuss novel investigational agents vying for approval in the MF space. Dr. Oleksowicz has written over 100 peer-reviewed publications and book chapters in major cancer journals and has served as the lead investigator in over 300 clinical trials. Over the span of her career, she has presented her research at national and international symposia, annual cancer conferences, web-based seminars and local lectures. Dr. Oleksowicz is also a reviewer for multiple cancer journals including Cancer, Transfusion, Journal of Medical Oncology, the Southern Journal of Medicine and the Journal of Urology.